Name |
Description of cell line |
Original reference |
Origin |
Sex & Age |
Source |
Cellosaurus (ExPaSy) |
Brain |
AF22 |
iPS derived Neuroepithelia stem (NES) cell line |
Falk et al., PLoS One 7(1) (2012) |
Skin |
Female, 36 |
NA |
|
U-87 MG* |
Glioblastoma, astrocytoma cell line |
Ponten J., Macintyre EH., Acta Pathol. Microbiol. Scand. 74: 465-486 (1968) |
Brain |
Male, 44 |
LGC/ATCC |
CVCL_0022 Cancer cell line |
U-251 MG |
Glioblastoma cell line |
Westermark B., Int J Cancer12: 438 (1973) |
Brain |
Male |
BW1 |
CVCL_0021 Cancer cell line |
U-138 MG |
Glioblastoma cell line |
Ponten et al., Acta Pathol Microbiol Scand 74: 465 (1968) |
Brain |
Male, 47 |
DSMZ |
CVCL_0020 Cancer cell line |
SH-SY5Y |
Metastatic neuroblastoma, clonal subline of neuroepithelioma cell line SK-N-SH |
Biedler et al., Cancer Res 33: 2643 (1973) |
Bone marrow |
Female, 4 |
DSMZ |
CVCL_0019 Cancer cell line |
Myeloid |
HL-60 |
Acute promyelocytic leukemia (APL) cell line |
Collins et al., Nature 270: 347-349 (1977) |
Peripheral blood |
Female, 35 |
DSMZ |
CVCL_0002 Cancer cell line |
HEL |
Erythroleukemia cell line (AML M6 in relapse after treatment for Hodgkin's disease) |
Martin et al., Science 216: 1233 (1982) |
Peripheral blood |
Male, 30 |
DSMZ |
CVCL_0001 Cancer cell line |
HMC-1 |
Mastcell leukemia cell line |
Butterfield et al., Leukemia Res. 12: 345-355 (1988) |
Peripheral blood |
Male, 52 |
KN2 |
CVCL_0003 Cancer cell line |
K-562 |
Chronic myeloid leukemia (CML) cell line |
Lozzio et al., J Natl Cancer Inst 50: 535 (1973) |
Pleural effusion |
Female, 53 |
DSMZ |
CVCL_0004 Cancer cell line |
NB-4 |
Acute promyelocytic leukemia (APL) cell line |
Lanotte et al., Blood 77: 1080 (1991) |
Bone marrow |
Female, 23 |
DSMZ |
CVCL_0005 Cancer cell line |
THP-1 |
Acute monocytic leukemia (AML) cell line |
Tsuchiya et al., Int J Cancer 26: 171 (1980) |
Peripheral blood |
Male, 1 |
DSMZ |
CVCL_0006 Cancer cell line |
U-937 |
Myelomonocytic histiocytic lymphoma cell line |
Sundström C, Nilsson K., Int J Cancer 17:565-577 (1976) |
Pleural effusion |
Male, 37 |
KN2 |
CVCL_0007 Cancer cell line |
Lymphoid |
HDLM-2 |
Hodgkin lymphoma cell line |
Drexler et al., Leuk Res 10: 487 (1986) |
Pleural effusion |
Male, 74 |
DSMZ |
CVCL_0009 Cancer cell line |
U-698 |
B-cell lymphoma cell line (lymphoblastic lymphosarcoma) |
Nilsson et al., Int J Cancer 13: 808-823 (1974) |
Tonsil |
Male, 7 |
DSMZ |
CVCL_0017 Cancer cell line |
U-266/84 |
Multiple myeloma cell line (1984, in vitro differentiated) |
Hellman et al., Eur J Immunol 18:905-910 (1988) |
Peripheral blood |
Male, 53 |
KN2 |
CVCL_0016 Cancer cell line |
U-266/70 |
Multiple myeloma cell line (1970, IL-6-dependent) |
Nilsson et al Clin Exp Immunol 7:477-489 (1970) |
Peripheral blood |
Male, 53 |
KN2 |
CVCL_0015 Cancer cell line |
RPMI-8226 |
Multiple myeloma cell line |
Matsuoka et al., Proc Soc Exp Biol Med 125: 1246 (1967) |
Peripheral blood |
Male, 61 |
DSMZ |
CVCL_0014 Cancer cell line |
REH** |
Pre-B cell leukemia cell line (ALL, first relapse) |
Rosenfeld et al., Nature 267: 841–3 (1977) |
Peripheral blood |
Female, 15 |
DSMZ |
CVCL_1650 Cancer cell line |
MOLT-4 |
Acute lymphoblastic leukemia (T-ALL) cell line |
Minowada et al., J Natl Cancer Inst 49: 891 (1972) |
Peripheral blood |
Male, 19 |
DSMZ |
CVCL_0013 Cancer cell line |
LP-1 |
Multiple myeloma cell line |
Pegoraro et al., Blood 73: 1020 (1989) |
Peripheral blood |
Female, 56 |
DSMZ |
CVCL_0012 Cancer cell line |
Karpas-707 |
Multiple myeloma cell line |
Karpas et al., Lancet Apr 24;1(8278): 931-3 (1982) |
Bone marrow and peripheral blood |
Male, 53 |
KN2 |
CVCL_0010 Cancer cell line |
Daudi |
Human Burkitt lymphoma cell line |
Klein et al., Cancer Res 28: 1300 (1968) |
Orbital biopsy |
Male, 16 |
DSMZ |
CVCL_0008 Cancer cell line |
Lung |
A549 |
Lung carcinoma cell line |
Giard et al., J Natl Cancer Inst 51: 1417 (1973) |
Lung |
Male, 58 |
DSMZ |
CVCL_0023 Cancer cell line |
SCLC-21H |
Small cell lung carcinoma cell line |
Bepler et al., J Cancer Res Clin Oncol 113: 31 (1987) |
Pleural effusion |
Male, 46 |
DSMZ |
CVCL_0024 Cancer cell line |
Abdominal |
CACO-2 |
Colon adenocarcinoma cell line |
Fogh J., et al. J. Natl. Cancer Inst. 58: 209 (1977) |
Colon |
Male, 72 |
DSMZ |
CVCL_0025 Cancer cell line |
CAPAN-2 |
Pancreas adenocarcinoma cell line |
Kyriazis et al., Cancer Res 46: 5810 (1986) |
Pancreas |
Male, 56 |
DSMZ |
CVCL_0026 Cancer cell line |
Hep G2 |
Hepatocellular carcinoma cell line |
Aden et al., Nature 282: 615 (1979) |
Liver |
Male, 15 |
DSMZ |
CVCL_0027 Cancer cell line |
Breast, female reproductive system |
SK-BR-3 |
Metastatic breast adenocarcinoma cell line |
Fogh J, editor. Human tumor cells in vitro. New York: Plenum Press (1975) |
Pleural effusion |
Female, 43 |
LGC/ATCC |
CVCL_0033 Cancer cell line |
SiHa |
Cervical squamous cell carcinoma cell line, integrated 1-2 copies of HPV16 |
Friedl F. et al.Proc., Soc. Exp. Biol. Med. 135: 543-545 (1970) |
Cervix |
Female, 55 |
LGC/ATCC |
CVCL_0032 Cancer cell line |
MCF7 |
Metastatic breast adenocarcinoma cell line |
Soule et al., J Natl Cancer Inst 51: 1409 (1973) |
Pleural effusion |
Female, 69 |
DSMZ |
CVCL_0031 Cancer cell line |
EFO-21 |
Metastatic ovarian serous cystadenocarcinoma cell line |
Simon et al., J Natl Cancer Inst 70: 839 (1983) |
Ascites |
Female, 56 |
DSMZ |
CVCL_0029 Cancer cell line |
AN3-CA |
Metastatic endometrial adenocarcinoma cell line |
Dawe et al., J Natl Cancer Inst 33: 441 (1964) |
Lymph node |
Female, 55 |
DSMZ |
CVCL_0028 Cancer cell line |
HeLa |
Cervical epithelial adenocarcinoma cell line |
Scherer et al., J Exp Med 97: 695 (1953) |
Cervix |
Female, 31 |
DSMZ |
CVCL_0030 Cancer cell line |
Renal, urinary, male reproductive system |
HEK 293 |
Embryonal kidney cell line, transformed by adenovirus type 5 |
Graham et al., J Gen Virol 36: 59 (1977) |
Embryonal kidney |
Female |
DSMZ |
CVCL_0045 Transformed cell line |
NTERA-2 |
Metastatic embryonal carcinoma cell line, cloned from TERA-2 |
Fogh & Trempe, Human Tumor Cells in Vitro : 115 (1975) |
|
Male, 22 |
DSMZ |
CVCL_0034 Cancer cell line |
PC-3 |
Metastatic poorly differentiated prostate adenocarcinoma cell line |
Kaighn et al., Invest Urol 17: 16-23 (1979) |
Bone marrow |
Male, 62 |
DSMZ |
CVCL_0035 Cancer cell line |
RT4 |
Urinary bladder transitional cell carcinoma cell line |
Rigby et al., Br J Cancer 24: 746 (1970) |
Urinary bladder |
Male, 63 |
DSMZ/ECACC |
CVCL_0036 Cancer cell line |
RPTEC TERT1 |
Proximal tubular epithelial cell line |
Wieser et al., Am J Physiol Renal Physiol 295(5): 1365-1375 (2008) |
Human kidney cortex |
Male |
Evercyte |
CVCL_K278 Telomerase immortalized cell line |
Skin |
A-431 |
Epidermoid carcinoma cell line |
Giard et al., J Natl Cancer Inst 51: 1417 (1973) |
Skin |
Female, 85 |
DSMZ |
CVCL_0037 Cancer cell line |
HaCaT |
Keratinocyte cell line |
Boukamp et al., J Cell Biol Mar 106(3): 761 (1988) |
Skin |
Male |
NEF3 |
CVCL_0038 Spontaneously immortalized cell line |
SK-MEL-30 |
Metastatic malignant melanoma cell line |
Carey et al., Proc Natl Acad Sci USA 73: 3278 (1976) |
Subcutis |
Male, 67 |
DSMZ |
CVCL_0039 Cancer cell line |
WM-115 |
Malignant melanoma cell line |
Westermark B. et al, Proc Natl Acad Sci U S A. Oct; 83(19): 7197 (1986) |
Skin |
Female, 58 |
BW1 |
CVCL_0040 Cancer cell line |
Sarcoma |
U-2197 |
Malignant fibrous histiocytoma cell line |
Genberg et al., Am J Pathol 135: 1185 (1989) |
Subcutis |
Male, 79 |
DSMZ |
CVCL_0043 Cancer cell line |
LHCN-M2 |
Adherent myoblast cell line |
Zhu et al., Aging Cell 6(4): 515-523 (2007) |
Satellite cells (from pectoralis major muscle) |
Male, 41 |
Evercyte |
CVCL_8890 Telomerase immortalized cell line |
ASC TERT1 |
Adipose tissue-derived mesenchymal stem cell line |
Wolbank S. et al., Tissue Eng Part A: Jul;15(7):1843-54 (2009) |
Adipose tissue |
Female |
Evercyte |
CVCL_U602 Telomerase immortalized cell line |
U-2 OS |
Osteosarcoma cell line |
Ponten J., Saksela E. Int. J. Cancer 2: 434 (1967) |
Bone |
Female, 15 |
LGC/ATCC |
CVCL_0042 Cancer cell line |
RH-30 |
Metastatic rhabdomyosarcoma cell line |
Douglass et al., Cytogenet Cell Genet 45: 148-155 (1987) |
Bone marrow |
Male, 17 |
DSMZ |
CVCL_0041 Cancer cell line |
Fibroblast |
HBF TERT88 |
Adherent brain fibroblast cell line |
NA |
Brain |
Female |
Evercyte |
CVCL_9Q52 Telomerase immortalized cell line |
BJ |
Adherent fibroblast cell line |
Bodnar AG., et al. Science 279: 349-352 (1998) |
Foreskin |
Male |
LGC/ATCC |
CVCL_3653 Finite cell line |
BJ hTERT+ |
Adherent BJ fibroblast cell line immortalized with ectopic expression of hTERT |
Bodnar et al., Science 279(5349): 349-352 (1998) |
Foreskin |
Male |
NA |
CVCL_6573 Telomerase immortalized cell line |
BJ hTERT+ SV40 Large T+ |
Adherent BJ fibroblast cell line immortalized with ectopic expression of hTERT, transformed with SV40 Large-T infection |
Bodnar et al., Science 279(5349): 349-352 (1998) |
Foreskin |
Male |
NA |
|
BJ hTERT+ SV40 Large T+ RasG12V |
Adherent BJ fibroblast cell line immortalized with ectopic expression of hTERT, transformed with SV40 Large-T infection, made metastasizing with oncogenic H-Ras |
Bodnar et al., Science 279(5349): 349-352 (1998) |
Foreskin |
Male |
NA |
|
Endothelial |
TIME |
Telomerase-immortalized human microvascular endothelial cells (pooled) |
Venetsanakos et el., Exp Cell Res., Feb 1;273(1): 21-33 (2002) |
Skin |
Male |
LCW54 |
CVCL_0047 Telomerase immortalized cell line |
HUVEC TERT2 |
Umbilical vein endothelial cell line |
NA |
Umbilical vein |
Female |
Evercyte |
CVCL_9Q53 Telomerase immortalized cell line |
Miscellaneous |
HTh 83 |
Anaplastic thyroid carcinoma cell line |
Dahlman et al., J. Pathol. 191: 376-386 (2000) |
Thyroid |
Male, 67 |
NEH5 |
CVCL_0046 Cancer cell line |
HTCEpi |
Telomerase-immortalized corneal epithelial cell line |
Robertson et al., Invest Ophthalmol Vis Sci 46(2): 470-478 (2005) |
Cornea |
Male, 62 |
Evercyte |
CVCL_AQ44 Telomerase immortalized cell line |
BEWO |
Metastatic choriocarcinoma cell line |
Pattillo et al., Cancer Res 28: 1231-1236 (1968) |
Brain |
Male |
DSMZ |
CVCL_0044 Cancer cell line |
Mouse |
NIH 3T3 |
Mouse embryonal fibroblast cell line |
Aaronson et al., J Cell Physio 72(2): 141-148 (1968) |
Embryo |
|
DSMZ |
CVCL_0594 Spontaneously immortalized cell line |
|
|
Schematic description of hematopoietic differentiation lineages, and cellular origin for hematopoietic cell lines.